Uwe Wolfrum

Prof. Uwe Wolfrum

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2007 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
TMTina Maerker
Tina Maerker
EWErwin van Wijk
Erwin van Wijk
NONora Overlack
Nora Overlack
FKFerry F.J. Kersten
Ferry F.J. Kersten
JMJoAnn McGee
JoAnn McGee
UWUwe Wolfrum
Uwe Wolfrum
The human Usher syndrome (USH) is the most frequent cause of combined deaf–blindness. USH is genetically heterogeneous with at least 12 chromosomal loci assigned to three clinical types, USH1–3. Although these USH types exhibit similar phenotypes in human, the corresponding gene products belong to very different protein classes and families. The scaffold protein harmonin (USH1C) was shown to integrate all identified USH1 and USH2 molecules into protein networks. Here, we analyzed a protein network organized in the absence of harmonin by the scaffold proteins SANS (USH1G) and whirlin (USH2D). Immunoelectron microscopic analyses disclosed the colocalization of all network components in the apical inner segment collar and the ciliary apparatus of mammalian photoreceptor cells. In this complex, whirlin and SANS directly interact. Furthermore, SANS provides a linkage to the microtubule transport machinery, whereas whirlin may anchor USH2A isoform b and VLGR1b (very large G-protein coupled receptor 1b) via binding to their cytodomains at specific membrane domains. The long ectodomains of both transmembrane proteins extend into the gap between the adjacent membranes of the connecting cilium and the apical inner segment. Analyses of Vlgr1/del7TM mice revealed the ectodomain of VLGR1b as a component of fibrous links present in this gap. Comparative analyses of mouse and Xenopus photoreceptors demonstrated that this USH protein network is also part of the periciliary ridge complex in Xenopus. Since this structural specialization in amphibian photoreceptor cells defines a specialized membrane domain for docking and fusion of transport vesicles, we suggest a prominent role of the USH proteins in cargo shipment.

1 September 2017 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
HMHelen May-Simera
Helen May-Simera
KNKerstin Nagel-Wolfrum
Kerstin Nagel-Wolfrum
UWUwe Wolfrum
Uwe Wolfrum

21 November 2005 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JRJan Reiners
Jan Reiners
EWErwin van Wijk
Erwin van Wijk
TMTina Märker
Tina Märker
UZUlrike Zimmermann
Ulrike Zimmermann
KJKarin Jürgens
Karin Jürgens
UWUwe Wolfrum
Uwe Wolfrum
Usher syndrome (USH) is the most frequent cause of combined deaf-blindness in man. USH is clinically and genetically heterogeneous with at least 11 chromosomal loci assigned to the three USH types ( USH1A-G , USH2A-C , USH3A ). Although the different USH types exhibit almost the same phenotype in human, the identified USH genes encode for proteins which belong to very different protein classes and families. We and others recently reported that the scaffold protein harmonin ( USH1C -gene product) integrates all identified USH1 molecules in a USH1-protein network. Here, we investigated the relationship between the USH2 molecules and this USH1-protein network. We show a molecular interaction between the scaffold protein harmonin (USH1C) and the USH2A protein, VLGR1 (USH2C) and the candidate for USH2B, NBC3. We pinpoint these interactions to interactions between the PDZ1 domain of harmonin and the PDZ-binding motifs at the C-termini of the USH2 proteins and NBC3. We demonstrate that USH2A, VLGR1 and NBC3 are co-expressed with the USH1-protein harmonin in the synaptic terminals of both retinal photoreceptors and inner ear hair cells. In hair cells, these USH proteins are also localized in the signal uptaking stereocilia. Our data indicate that the USH2 proteins and NBC3 are further partners in the supramolecular USH-protein network in the retina and inner ear which shed new light on the function of USH2 proteins and the entire USH-protein network. These findings provide first evidence for a molecular linkage between the pathophysiology in USH1 and USH2. The organization of USH molecules in a mutual ‘interactome’ related to the disease can explain the common phenotype in USH.

5 April 2010 in Journal of Cell Biology
Verified
Journal Article
Open access
TSTina Sedmak
Tina Sedmak
UWUwe Wolfrum
Uwe Wolfrum
The assembly and maintenance of cilia require intraflagellar transport (IFT), a process mediated by molecular motors and IFT particles. Although IFT is a focus of current intense research, the spatial distribution of individual IFT proteins remains elusive. In this study, we analyzed the subcellular localization of IFT proteins in retinal cells by high resolution immunofluorescence and immunoelectron microscopy. We report that IFT proteins are differentially localized in subcompartments of photoreceptor cilia and in defined periciliary target domains for cytoplasmic transport, where they are associated with transport vesicles. IFT20 is not in the IFT core complex in photoreceptor cilia but accompanies Golgi-based sorting and vesicle trafficking of ciliary cargo. Moreover, we identify a nonciliary IFT system containing a subset of IFT proteins in dendrites of retinal neurons. Collectively, we provide evidence to implicate the differential composition of IFT systems in cells with and without primary cilia, thereby supporting new functions for IFT beyond its well-established role in cilia.

17 February 2016 in BioDrugs
Verified
Journal Article
Closed access
PDF file
KNKerstin Nagel-Wolfrum
Kerstin Nagel-Wolfrum
FMFabian Möller
Fabian Möller
IPInessa Penner
Inessa Penner
TBTimor Baasov
Timor Baasov
UWUwe Wolfrum
Uwe Wolfrum

1 May 2011 in Human Gene Therapy
Verified
Journal Article
Closed access
TGT. Goldmann
T. Goldmann
NON. Overlack
N. Overlack
UWUwe Wolfrum
Uwe Wolfrum
KNK. Nagel-Wolfrum
K. Nagel-Wolfrum
We investigated the therapeutic potential of the premature termination codon (PTC) readthrough-inducing drug PTC124 in treating the retinal phenotype of Usher syndrome, caused by a nonsense mutation in the USH1C gene. Applications in cell culture, organotypic retina cultures, and mice in vivo revealed significant readthrough and the recovery of protein function. In comparison with other readthrough drugs, namely the clinically approved readthrough-inducing aminoglycoside gentamicin, PTC124 exhibits significant better retinal biocompatibility. Its high readthrough efficiency in combination with excellent biocompatibility makes PTC124 a promising therapeutic agent for PTCs in USH1C, as well as other ocular and nonocular genetic diseases.